• Skip to primary navigation
  • Skip to main content
BC

biochimica clinica

en_US English
en_US English it_IT Italian
  • Home
  • Case reports
  • Ahead of print e Ultimo Fascicolo - Accedi per visualizzare gli articoli
  • BC Issues until 2024
  • Submission
  • Istruction for authors
  • Search

CASI CLINICI – Case Reports

Volume:

Biochimica Clinica 2013; 37(3) 246-249

Published on-line:

DOI:

Download in PDF:
Authentication required

Troponin elevation reflects myocardial injury in carbon monoxide poisoning

AUTHORS

Martina Montagnana1, Giuseppe Lippi2
1Sezione di Biochimica Clinica, Dipartimento di Scienze della Vita e della Riproduzione, Università degli Studi, Verona
2Unità Operativa Diagnostica Ematochimica, Dipartimento di Patologia e Medicina di Laboratorio, Azienda Ospedaliero-Universitaria, Parma

ABSTRACT

We describe the case of a 48-year-old white man, who was admitted to the emergency department with neurologic deficits and high suspicion of carbon monoxide (CO) poisoning. Blood carboxyhemoglobin (COHb) level was found substantially increased (i.e., 18%). Clinical symptoms of myocardial infarction were lacking and the medical history was negative for major risk factors of coronary heart disease. However, electrocardiogram and troponin value were both suggestive for an acute coronary syndrome (i.e., a highly-sensitive troponin T value of 0.12 μg/L), while the echocardiogram showed hypokinesia of left ventricular apical lateral wall. The coronary angiogram performed one week after admission did not reveal the presence of coronary obstructions. It is hence assumed that high levels of COHb in blood, such as after CO exposure, may trigger myocardial injury by severe generalized tissue hypoxia (i.e., impaired oxygen delivery) and a direct toxic effect on myocardium. Contributing factors that also decrease myocardial oxygenation include inadequate myocardial perfusion and prothrombotic state. This case report suggests that increased troponin values, especially when measured with highly-sensitive immunoassays, may be observed in patients with CO poisoning, and mirror the presence of myocardial injury. Therefore, although the measurement of cardiac biomarkers may be advisable in the presence of CO toxicity to identify cardiac involvement, caution should be used when troubleshooting the underlying source of troponin elevations in order to preven t overdiagnosis or misdiagnosis of acute coronary syndrome.

REFERENCES